JF
FENC icon

Jump Financial’s Fennec Pharmaceuticals FENC Stock Holding History

Jump Financial’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,000
Closed -$211K – 1938
2024
Q1 		$211K Buy
19,000
+4,900
+35% +$49.2K 0.01% 1653
2023
Q4 		$158K Buy
+14,100
New +$117K 0.01% 1610
2023
Q2 		– Sell
-14,220
Closed -$118K – 1909
2023
Q1 		$118K Sell
14,220
-6,771
-32% -$62.8K ﹤0.01% 1422
2022
Q4 		$202K Buy
+20,991
New +$186K 0.01% 1285

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Jump Financial's FENC Position: Q2 2024 in Review

Jump Financial sold out of Fennec Pharmaceuticals (FENC) in Q2 2024, closing a stake of 19,000 shares — an estimated $211K sold.

Jump Financial first reported a position in FENC in Q4 2022 and held it in 4 quarters. The position peaked at $211K in Q1 2024. 64 funds tracked by Wall St. Rank hold FENC as of Q2 2024.

  • Jump Financial reported no remaining Fennec Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 19,000 Fennec Pharmaceuticals shares in Q2 2024, an estimated $211K.
  • Jump Financial first reported a position in Fennec Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Jump Financial's Fennec Pharmaceuticals position peaked at $211K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.